News
All News
Publications
All PublicationsPharmTechPharmTech Europe
Multimedia
All VideosAsk the ExpertBehind The HeadlinesDrug Digest VideosDrug Solutions Podcast
Conferences
Conference CoverageConference Listing
More
Webcasts
Resources
ICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPartnersPeer-Reviewed ResearchPharmTech ProductsPharma InsightsSponsored PodcastsSponsored VideosSponsored eBooksState of the ScienceWhitepapers

Subscribe

  • News
  • Publications
  • Multimedia
  • Conferences
  • Webcasts
  • Resources
  • Subscribe
  • Analytics
    • Bio/Pharmaceutical Analysis Techniques
    • Laboratory Equipment and Instruments
  • Data and Artificial Intelligence
  • Dosage Forms
    • Solid/Semi-Solid Dosage
    • Specialty Dosage Drugs
    • Parenterals and Injectables
    • Inhalation Drugs
  • Drug Development
    • Intellectual Property and Patents
    • Process and Scaling
    • APIs and Excipients
    • Ingredients
    • Formulation and Drug Delivery
  • Manufacturing
    • Aseptic/Sterile Processing
    • Equipment
    • Process and Automation
    • Manufacturing, Parenterals and Injectables
    • Manufacturing, Biosimilars and Biobetters
    • Manufacturing, Inhalation Drugs
    • Manufacturing, Solid and Semi-Solid Dosage Drugs
    • Manufacturing, Cell Therapies
    • Manufacturing, Biologic Drugs
    • Supply Chain
    • Manufacturing, Gene Therapies
    • Packaging and Distribution
  • Outsourcing
    • Contract Research Services
    • Contract Analytical Services
    • Contract Development Services
    • Regulatory Consulting
    • Logistics and Distribution
    • Contract Manufacturing Services
  • Quality Systems
    • Ask the Expert
    • Quality Assurance/Quality Control
    • Regulatory Oversight and Compliance
Spotlight -
Analytics|
Dosage Forms|
Drug Development|
Manufacturing|
Outsourcing|
Quality Systems
Advertisement
News|Articles|August 17, 2016

Characterizing Microstructural Differences of Semisolid Topical Dosage Forms

Author(s)Sponsor's Content

Advertisement

 

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Advertisement

Related Content

Advertisement
Silver Spring, MD, USA - June 25, 2022: The FDA White Oak Campus, headquarters of the United States Food and Drug Administration, a federal agency of the Department of Health and Human Services (HHS). | Image Credit: © Tada Images - stock.adobe.com

FDA, Duke University Planning Epinephrine Access Workshop for December

ByPatrick Lavery
November 24th 2025

FAQ: Key AI Applications in Drug Development

ByPatrick Lavery
November 21st 2025

Molecular Dynamics and Quantum Calculations: AAPS Thermo Fisher Interview, Part Two

ByFeliza Mirasol,Patrick Lavery
November 19th 2025

Leveraging AI/ML to Reduce Risk in Drug Development: Part One

ByFeliza Mirasol,Patrick Lavery
November 18th 2025

Nuclear Waste to Medicine: The UK’s Lead-212 Strategy for Cancer Care

ByPatrick Lavery
November 18th 2025
Advertisement
Advertisement

Trending on Pharmaceutical Technology

1

FDA, Duke University Planning Epinephrine Access Workshop for December

2

Industry Expert Panel Weighs CNPV Benefits, Risks, and Readiness: Part II

3

How ten23 health is Advancing Patient-Centric Drug Delivery

4

Industry Expert Panel Weighs CNPV Benefits, Risks, and Readiness: Part I

5

FAQ: Key AI Applications in Drug Development

  • About Us
  • Advertise
  • Contact Us
  • Editorial Info
  • Editorial Advisory Board
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us